Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

How to diagnose multiple system atrophy.

Niall P Quinn1

  • 1Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, London, UK.

Movement Disorders : Official Journal of the Movement Disorder Society
|August 11, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development and Validation of a Prognostic Model to Predict Overall Survival in Multiple System Atrophy.

Movement disorders clinical practice·2023
Same author

Argentine Tango for Parkinson's Disease: Much Better Than a Zimmer!

Movement disorders clinical practice·2021
Same author

IQGAP1 Is a Scaffold of the Core Proteins of the Hippo Pathway and Negatively Regulates the Pro-Apoptotic Signal Mediated by This Pathway.

Cells·2021
Same author

Soft signs in movement disorders: friends or foes?

Journal of neurology, neurosurgery, and psychiatry·2018
Same author

Recommendations of the Global Multiple System Atrophy Research Roadmap Meeting.

Neurology·2017
Same author

Development and validation of a carers quality-of-life questionnaire for parkinsonism (PQoL Carers).

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation·2015
Same journal

Gene Therapy for Amino Acid Decarboxylase Deficiency: Clinical and Imaging Outcomes in a French Cohort.

Movement disorders : official journal of the Movement Disorder Society·2026
Same journal

Alzheimer's Disease Cerebrospinal Fluid Biomarkers Predict Survival in Progressive Supranuclear Palsy.

Movement disorders : official journal of the Movement Disorder Society·2026
Same journal

Hyperhomocysteinemia and Vitamin B Deficiency as Potential Aggravating Factors in Huntington's Disease: A Prospective Monocentric Study.

Movement disorders : official journal of the Movement Disorder Society·2026
Same journal

Longitudinal Dynamics of Polyglutamine-Expanded ATXN3 in Biofluids of Spinocerebellar Ataxia Type 3.

Movement disorders : official journal of the Movement Disorder Society·2026
Same journal

Putamen Structural-Functional Decoupling as an Early-Stage Candidate Imaging Marker for Motor Severity in Spinocerebellar Ataxia Type 3.

Movement disorders : official journal of the Movement Disorder Society·2026
Same journal

Melanopsin-Mediated Post-Illumination Pupillary Response in Idiopathic Rapid Eye Movement (REM) Sleep Behavior Disorder and Parkinson's Disease.

Movement disorders : official journal of the Movement Disorder Society·2026
See all related articles

Diagnosing multiple system atrophy (MSA) is challenging and relies on clinical assessment. Current criteria may not capture all cases, prompting research into additional diagnostic

Area of Science:

  • Neurology
  • Clinical Diagnostics

Background:

  • Multiple system atrophy (MSA) diagnosis during a patient's lifetime is exclusively clinical.
  • Established consensus diagnostic criteria exist but do not significantly improve diagnostic accuracy over clinicians' assessments.
  • Some patients meeting criteria may not be diagnosed, while others show "red flags" suggestive of MSA.

Purpose of the Study:

  • To evaluate the diagnostic utility of "red flags" in identifying potential MSA cases.
  • To assess the value of various investigations in improving MSA diagnosis.
  • To inform future revisions of diagnostic criteria for multiple system atrophy.

Main Methods:

  • Clinical assessment and application of consensus diagnostic criteria.
  • Identification and analysis of "red flags" indicative of MSA.

Related Experiment Videos

  • Investigation into the effectiveness of supplementary diagnostic tools and tests.

    • Main Results:

    • Clinical diagnosis remains the primary method for identifying multiple system atrophy.
    • Current consensus criteria may not encompass all individuals with MSA.
    • The diagnostic value of "red flags" and supplementary investigations is under active investigation.

    Conclusions:

    • Improving the accuracy of multiple system atrophy diagnosis requires further research beyond current criteria.
    • Exploring "red flags" and new investigations may enhance future diagnostic capabilities.
    • Refining diagnostic criteria could lead to earlier and more accurate identification of MSA patients.